Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate

Cell Death & Disease, Published online: 13 April 2024; doi:10.1038/s41419-024-06653-2Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate

Source: Cell death and disease - April 13, 2024 Category: Internal Medicine Authors: Francesco Marrocco Elisabetta Falvo Luciana Mosca Giada Tisci Alessandro Arcovito Alice Reccagni Cristina Limatola Roberta Bernardini Pierpaolo Ceci Giuseppina D ’Alessandro Gianni Colotti Source Type: research